In line with our result, in an Egyptian study, the differences in BAALC and ERG expressions among AML subtypes were not significant.9 Also, in this study, the number of patients in M1 was the highest in terms of BAALC expression and in M2 and M3 in terms of ERG expression9 which was different from our study. This evidence concerns the gene ERG and acute myeloid leukemia.